New HIV injection LP-98 tested in small safety trial
NCT ID NCT06560489
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new drug called LP-98 in 40 people with HIV who had not taken any HIV medications before. Participants received different doses of LP-98 as a shot under the skin every two weeks for a total of four doses. The main goal was to check if the drug is safe and how the body handles it, not to see if it controls the virus. This is an early step in finding out if LP-98 could become a future treatment option.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
LP-98
What this could lead to
If successful, this could point toward a new injectable treatment option for HIV that helps control the virus.
What could go wrong
This is a very early, small study focused on safety and dosing, not on proving the drug works. Many drugs fail in early trials, and it may not lead to an effective treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Henan Provincial Hospital for Infectious Diseases (Zhengzhou Sixth People's Hospital)
Zhengzhou, Henan, China